ETON•benzinga•
B. Riley Securities Initiates Coverage On Eton Pharmaceuticals with Buy Rating, Announces Price Target of $21
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga